Herein, we report the case of an elderly patient with anaplastic lymphoma kinase (ALK)-rearranged metastatic lung adenocarcinoma diagnosed during long-term treatment for recurrent RA-OP and successfully treated with alectinib. This evidence concerns the gene ALK and rheumatoid arthritis.